CLAUDIA RUIZ: Open Payments
NPI 1316975675 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 42 payments from 11 companies in 2025. Trend: 2023 $583 · 2024 $864 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $157 |
| Neurocrine BioSciences, Inc. | 7 | $155 |
| Axsome Therapeutics, Inc. | 5 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
Products named: ARISTADA, INGREZZA, Auvelity, REXULTI, TRINTELLIX, AUSTEDO XR, CAPLYTA, SPRAVATO.
Industry payments across NM — which companies pay providers there.
